Clinical Trial: Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Study

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906587) titled 'Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Study' on Oct. 14.

Brief Summary: This is a prospective, single-arm, phase II study. It aims to evaluate whether neoadjuvant targeted therapy combined with immunotherapy and chemotherapy is effective and safe in patients with locally advanced, resectable head and neck squamous cell carcinoma (HNSCC).

Study Start Date: Sept. 02

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinoma

Intervention: DRUG: Combining nimotuzumab and toripalimab with nab-paclitaxel plus cisplatin

This study incorporates targeted ...